News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PERSING DAVID H
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/24/2016 |
4
| PERSING DAVID H (EVP, Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 106 shares
@ $52.8, valued at
$5.6k
Exercised 281 restricted stock units
@ $0 |
|
| 08/02/2016 |
4
| PERSING DAVID H (EVP, Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 138 shares
@ $35.33, valued at
$4.9k
Exercised 366 restricted stock units
@ $0 |
|
| 07/25/2016 |
4
| PERSING DAVID H (EVP, Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 106 shares
@ $32.9, valued at
$3.5k
Exercised 281 restricted stock units
@ $0 |
|
| 05/03/2016 |
4
| PERSING DAVID H (EVP, Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 138 shares
@ $28.54, valued at
$3.9k
Exercised 365 restricted stock units
@ $0 |
|
| 04/29/2016 |
4
| PERSING DAVID H (EVP, Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 588 shares
@ $36.57, valued at
$21.5k
|
|
| 04/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/25/2016 |
4
| PERSING DAVID H (EVP, Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 106 shares
@ $34.98, valued at
$3.7k
Paid exercise price by delivering 128 shares
@ $35.34, valued at
$4.5k
Exercised 282 restricted stock units
@ $0
Exercised 339 restricted stock units
@ $0 |
|
| 10/30/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 177 shares
@ $40.91, valued at
$7.2k
Sold 5,000 shares
@ $41.35, valued at
$206.8k
Exercised 339 restricted stock units
@ $0
Exercised 5,000 options to buy
@ $11.94, valued at
$59.7k
|
|
| 10/28/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 177 shares
@ $40.26, valued at
$7.1k
Paid exercise price by delivering 158 shares
@ $40.48, valued at
$6.4k
Exercised 339 restricted stock units
@ $0
Exercised 302 restricted stock units
@ $0 |
|
| 10/22/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 10,000 shares
@ $40.45, valued at
$404.5k
Sold 5,000 shares
@ $40.53, valued at
$202.7k
Sold 5,000 shares
@ $40.94, valued at
$204.7k
Exercised 20,000 options to buy
@ $11.94, valued at
$238.8k
|
|
| 09/09/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 5,000 shares
@ $37.43, valued at
$187.2k
Sold 5,000 shares
@ $37.8, valued at
$189k
Sold 5,000 shares
@ $38.18, valued at
$190.9k
Sold 5,000 shares
@ $38.56, valued at
$192.8k
Exercised 5,000 options to buy
@ $7.35, valued at
$36.8k
Exercised 10,000 options to buy
@ $11.94, valued at
$119.4k
Exercised 5,000 options to buy
@ $11.94, valued at
$59.7k
|
|
| 09/04/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 5,129 shares
@ $36.62, valued at
$187.8k
|
|
| 07/30/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 128 shares
@ $34.44, valued at
$4.4k
Exercised 338 restricted stock units
@ $0 |
|
| 07/25/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 128 shares
@ $33.8, valued at
$4.3k
Paid exercise price by delivering 114 shares
@ $34.53, valued at
$3.9k
Exercised 338 restricted stock units
@ $0
Exercised 302 restricted stock units
@ $0 |
|
| 05/01/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 128 shares
@ $38.66, valued at
$4.9k
Exercised 339 restricted stock units
@ $0
Granted 5,850 restricted stock units
@ $0
Granted 52,500 options to buy
@ $38.66, valued at
$2M
|
|
| 04/25/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 510 shares
@ $37.95, valued at
$19.4k
Paid exercise price by delivering 114 shares
@ $38.42, valued at
$4.4k
Exercised 1,355 restricted stock units
@ $0
Exercised 302 restricted stock units
@ $0 |
|
| 02/25/2013 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 15,000 shares
@ $36.1329, valued at
$542k
Exercised 15,000 options to buy
@ $7.38, valued at
$110.7k
|
|
| 10/31/2012 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 159 shares
@ $30.46, valued at
$4.8k
Exercised 339 restricted stock units
@ $0 |
|
| 10/29/2012 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 141 shares
@ $31.1, valued at
$4.4k
Exercised 302 restricted stock units
@ $0 |
|
| 07/26/2012 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 141 shares
@ $32.51, valued at
$4.6k
Exercised 302 restricted stock units
@ $0 |
|
| 07/03/2012 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 5,000 shares
@ $45.23, valued at
$226.2k
Sold 5,000 shares
@ $45.69, valued at
$228.5k
Exercised 10,000 options to buy
@ $7.38, valued at
$73.8k
|
|
| 06/28/2012 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 5,000 shares
@ $44.79, valued at
$224k
Exercised 5,000 options to buy
@ $7.38, valued at
$36.9k
|
|
| 05/01/2012 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 159 shares
@ $38.5, valued at
$6.1k
Exercised 339 restricted stock units
@ $0 |
|
| 04/26/2012 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 565 shares
@ $37.17, valued at
$21k
Granted 5,417 restricted stock units
@ $0
Granted 48,750 options to buy
@ $35.72, valued at
$1.7M
Exercised 1,209 restricted stock units
@ $0 |
|
| 01/31/2012 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 142 shares
@ $43.14, valued at
$6.1k
Exercised 338 restricted stock units
@ $0 |
|
| 12/29/2011 |
4/A
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 158 shares
@ $37.76, valued at
$6k
Paid exercise price by delivering 159 shares
@ $37.89, valued at
$6k
Exercised 338 restricted stock units
@ $0
Exercised 339 restricted stock units
@ $0 |
|
| 12/29/2011 |
4/A
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Paid exercise price by delivering 498 shares
@ $32.31, valued at
$16.1k
Exercised 1,355 restricted stock units
@ $0 |
|
| 11/01/2011 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 158 shares
@ $37.76, valued at
$6k
Sold 159 shares
@ $37.89, valued at
$6k
Exercised 338 restricted stock units
@ $0
Exercised 339 restricted stock units
@ $0 |
|
| 07/05/2011 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 5,000 shares
@ $35.15, valued at
$175.8k
Exercised 5,000 options to buy
@ $7.38, valued at
$36.9k
|
|
| 06/21/2011 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 4,715 shares
@ $32.85, valued at
$154.9k
Exercised 4,715 options to buy
@ $7.38, valued at
$34.8k
|
|
| 06/02/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2011 |
4
| PERSING DAVID H (Exec VP,Chief Med/Tech Officer) has filed a Form 4 on CEPHEID|
Txns:
| Sold 5,000 shares
@ $31.47, valued at
$157.4k
Sold 5,000 shares
@ $31.93, valued at
$159.7k
Exercised 5,000 options to buy
@ $7.38, valued at
$36.9k
Exercised 5,000 options to buy
@ $7.38, valued at
$36.9k
|
|
|
|
|